Dividend-adjusted total return · S&P 500 uses VOO · Aug 5, 2026 – Nov 3, 2026VHTS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −0.1% | +8.4% | +10.8% | +19.6% | +28.1% | +59.9% | +43.1% | +716.9% |
| Peer average | +0.6% | +4.0% | +6.1% | +21.0% | +29.0% | +81.2% | +28.9% | — |
| S&P 500 · VOO | +0.3% | −2.6% | −1.7% | +11.5% | +11.9% | +90.9% | +77.5% | — |
Key Statistics
Open all fund facts →- AUM
- $19.1B
- Expense ratio
- 0.09%
- Distribution yield
- 1.4%
- NAV
- $341.07
- Volume
- 388K
- Avg. volume 30D
- 248K
- High today
- $343.83
- Low today
- $339.99
- Previous close
- $341.27
- 52-week high
- $348.26
- 52-week low
- $264.97
- Our risk indicator
- 4/5
VHT in One Breath
VHT Among Health Care ETFs
YTDEnd-of-day Nov 4, 2026 · 33 Health care ETFs by YTD
$10,000 in VHT
5Y$10,000 in VHT became
$14,313
In the S&P 500 (VOO)
$17,749
Total return, dividends in · Oct 26, 2021 – Nov 3, 2026 · S&P 500 uses VOO
VHT’s Top Holdings
TodayLLYEli Lilly &12.9%JNJ8.8%ABBV6.5%MRK5.0%UNH4.7%TMO3.5%AMGN3.2%GILD2.6%ABT2.4%PFE2.3%ISRG2.0%DHR2.0%VRTX1.9%BMY1.8%MDT1.5%CVS1.5%MCK1.4%SYK1.3%ELV1.1%REGN1.1%390 more
LLYEli Lilly &12.9%JNJ8.8%ABBV6.5%MRK5.0%UNH4.7%TMO3.5%AMGN3.2%GILD2.6%ABT2.4%PFE2.3%ISRGDHR400 more
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsOther
Vanguard VHT · 412 holdings · tile size = share of the fund · as of Nov 3, 2026
What VHT Holds
TodayDrug Manufacturers - General43.4%
LLY 12.9 · JNJ 8.8 · ABBV 6.5 · MRK 5.0 · AMGN 3.2 · GILD 2.6 · PFE 2.3
Medical - Diagnostics & Research11.4%
TMO 3.5 · DHR 2.0 · NTRA · A · IQV · WAT · IDXX
Medical - Healthcare Plans9.5%
UNH 4.7 · CVS 1.5 · ELV 1.1 · CI 1.0 · HUM · CNC · MOH
Medical - Devices8.7%
ABT 2.4 · MDT 1.5 · SYK 1.3 · BSX · EW · DXCM · GEHC
Biotechnology8.2%
VRTX 1.9 · REGN 1.1 · MRNA · RVMD · ALNY · INSM · UTHR
Medical - Instruments & Supplies4.5%
ISRG 2.0 · BDX · RMD · WST · SOLV · MDLN · BAX
Other holdings14.3%
MCK 1.4 · HCA · COR · CAH · VEEV · ZTS · THC
Vanguard VHT · share of the fund by industry · as of Nov 3, 2026
Eli’s Share of VHT
Today12.9%
$129 of every $1,000 in VHT is Eli
Eli held by VHT
$2.5B
Vanguard VHT · each square = $10 of $1,000 · as of Nov 3, 2026
VHT’s Share of Health Care ETFs
Today17.5%
of the $109B in 39 Health care ETFs
$19.1B17.5%
$49.1B45.0%
$10.5B9.6%
$30.3B27.8%
Health care ETF AUM · Nov 4, 2026
VHT Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 4, 2026
Inside VHT
412 holdings · as of Nov 3, 2026VHT
Vanguard Health Care ETF
TodayDrug Manufacturers - General43.4%LLYEli Lilly &12.9%JNJ8.8%ABBV6.5%MRK5.0%AMGN3.2%GILDPFEBMYBIIBMedical - Diagnostics11.4%TMO3.5%DHRNTRAAIQVWATIDXXILMNMTDLHGHRVTYMedical - Healthcare Plans9.5%UNH4.7%CVSELVCIHUMCNCMedical - Devices8.7%ABT2.4%MDTSYKBSXEWDXCMGEHCBiotechnology8.2%VRTXREGNMRNARVMDALNYINSMUTHRINCY11 moreMedical - Instruments4.5%ISRG2.0%BDXOther14.3%MCKHCACORCAHVEEVZTSTHCVTRS9 more
Drug Manufacturers - General43.4%LLY12.9%JNJ8.8%ABBV6.5%MRK5.0%AMGNGILD3 moreMedical - Diagnostics11.4%TMO3.5%DHRNTRAAIQVWAT9 moreMedical - Healthcare Plans9.5%UNH4.7%CVSELVCIHUMCNCMedical - Devices8.7%ABTMDTSYKEWDXCMBiotechnology8.2%VRTXREGNMRNA19 moreMedical - Instruments4.5%ISRGBDXOther14.3%MCKHCACOR12 more
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly & | 12.93% |
| 2 | JNJ | Johnson & Johnson | 8.78% |
| 3 | ABBV | AbbVie | 6.45% |
| 4 | MRK | Merck & | 5.01% |
| 5 | UNH | UnitedHealth Group | 4.65% |
| 6 | TMO | Thermo Fisher Scientific | 3.50% |
| 7 | AMGN | Amgen | 3.18% |
| 8 | GILD | Gilead Sciences | 2.58% |
| 9 | ABT | Abbott Laboratories | 2.40% |
| 10 | PFE | Pfizer | 2.27% |
Drug Manufacturers - GeneralMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyMedical - InstrumentsOther
Vanguard VHT · current holdings by weight · as of Nov 3, 2026 · each tile is one holding · top 20 = 67.4%
How It Compares
VHT
Vanguard Health Care ETF’s Peers
TodayHealth care peers · Today’s and past-year returns · as of Nov 4, 2026 · sorted by AUM
Head to Head
Put VHT head to head with XLV →XLV vs VHT
YTDYear to date
XLV wins+0.7 pts
Past year
XLV wins+1.6 pts
Fee
XLV winslower fee
Yield
Level
AUM
XLV2.6× more
3–0XLV wins
SPDR XLV and Vanguard VHT · year-to-date · as of Nov 4, 2026 · AUM not scored
VHT vs VOO
YTDVHT · Vanguard Health Care
+19.6%
VOO · S&P 500
+11.5%
Gap
8.1 pts
Vanguard VHT and Vanguard VOO · Today total return · as of Nov 4, 2026
VHT vs Its Peer Average
YTDVHTAvsBPeer average
1D−0.1%+0.6%
1M+8.4%+4.0%
3M+10.8%+6.1%
YTD+19.6%+21.0%
1Y+28.1%+29.0%
3Y+59.9%+81.2%
5Y+43.1%+28.9%
3–4Peer average wins
38 Health care peers · each row scaled to its leader
The Details
VHT
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y15.77%
Deepest drop · 1Y−10.4%
Lowest point · 5Y−13.3%
52-week range
$340.80
$264.97−2.1% from the high$348.26
Vanguard VHT · past-year price moves · as of Nov 4, 2026
VHT
Fund Facts
Today2004launched Jan 26
Tracks[…]
Exchange · CUSIPAMEX · 92204A504
StructureETF
Leverage1x
Cost on $10,000$9 a year
Go deeper
Vanguard VHT · fund facts · as of Nov 4, 2026
VHT
Payouts by Year
13Y$0.97per share, Sep 2026
Distribution yield1.4%
PaidEvery quarter
Latest ex-date · paidSep 23 · Sep 25, 2026
12 payouts added up$12.36 a share
Vanguard VHT · distributions by ex-date · 2014–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-08-31 ↗SEC reported portfolio · 2026-05-31 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-02-28 ↗SEC reported portfolio · 2025-11-30 ↗prospectus · SEC 497 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-08-31 ↗SEC reported portfolio · 2025-05-31 ↗SEC reported portfolio · 2025-02-28 ↗SEC reported portfolio · 2024-11-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-08-31 ↗SEC reported portfolio · 2024-05-31 ↗SEC reported portfolio · 2024-02-29 ↗SEC reported portfolio · 2023-11-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-08-31 ↗SEC reported portfolio · 2023-05-31 ↗SEC reported portfolio · 2023-02-28 ↗SEC reported portfolio · 2022-11-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-08-31 ↗SEC reported portfolio · 2022-05-31 ↗SEC reported portfolio · 2022-02-28 ↗SEC reported portfolio · 2021-11-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-08-31 ↗SEC reported portfolio · 2021-05-31 ↗
Trading & Liquidity
Net asset value$341.07
Premium / discount[…]
Median spread · 30D[…]
Volume today388K
Average volume · 30D248K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.09%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$9.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 23, 2026 | Sep 25, 2026 | $0.97 |
| Jun 24, 2026 | Jun 26, 2026 | $0.99 |
| Mar 24, 2026 | Mar 26, 2026 | $0.99 |
| Dec 17, 2025 | Dec 19, 2025 | $1.67 |
| Sep 24, 2025 | Sep 26, 2025 | $1.08 |
| Jun 26, 2025 | Jun 30, 2025 | $0.96 |
| Mar 25, 2025 | Mar 27, 2025 | $0.94 |
| Dec 18, 2024 | Dec 20, 2024 | $0.92 |
| Sep 27, 2024 | Oct 1, 2024 | $1.17 |
| Jun 28, 2024 | Jul 2, 2024 | $0.97 |
| Mar 22, 2024 | Mar 27, 2024 | $0.82 |
| Dec 19, 2023 | Dec 22, 2023 | $0.89 |
Issuer contentFrom VanguardHear the strategy from the people behind VHT.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →